Merxin
Private Company
Funding information not available
Overview
Merxin is a specialized drug delivery device company founded in 2016, operating as a service and supply partner to the pharmaceutical industry. It leverages over 100 years of collective team experience in OINDPs to design, develop, and supply inhaler platforms, aiming to reduce development time, cost, and risk for its clients. The company is ISO13485:2016 certified and positions itself as an expert partner rather than a cost center, helping customers generate revenue through efficient device development and regulatory support. Its business model is based on providing devices and expertise as a service to drug developers.
Technology Platform
Portfolio of inhaler device platforms including multidose dry powder inhalers (MRX006), capsule-based dry powder inhalers (MRX003), and soft mist inhalers (MRX004). Expertise in device design, formulation integration, and regulatory strategy for Orally Inhaled and Nasal Drug Products (OINDPs).
Opportunities
Risk Factors
Competitive Landscape
Merxin competes in the inhaler device design and supply market against large Contract Development and Manufacturing Organizations (CDMOs) with device divisions and other specialized drug delivery companies. Its differentiation is based on deep, focused OINDP expertise, a flexible partner model, and a portfolio covering multiple device types. Competition is intense on cost, technical capability, and regulatory track record.